Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 65.97
+1.21 (1.87%)
At close: Jun 19, 2026
BOM:524518 Revenue
In the fiscal year ending March 31, 2026, Krebs Biochemicals & Industries had annual revenue of 237.32M INR, down -45.21%. Krebs Biochemicals & Industries had revenue of 68.09M in the quarter ending March 31, 2026, with 11.62% growth.
Revenue
237.32M
Revenue Growth
-45.21%
P/S Ratio
5.99
Revenue / Employee
1.17M
Employees
202
Market Cap
1.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 237.32M | -195.80M | -45.21% |
| Mar 31, 2025 | 433.12M | -71.10M | -14.10% |
| Mar 31, 2024 | 504.22M | -17.13M | -3.29% |
| Mar 31, 2023 | 521.34M | -75.69M | -12.68% |
| Mar 31, 2022 | 597.03M | 70.20M | 13.32% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.72B |
| Kimia Biosciences | 1.15B |
| Panchsheel Organics | 1.07B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 902.48M |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 357.23M |
| Accretion Nutraveda | 337.16M |
Krebs Biochemicals & Industries News
- 1 year ago - Krebs Biochemicals & Industries halts production following order from Andhra Pradesh Pollution Control Board - Business Upturn